GH
BIO icon

GAM Holding’s Bio-Rad Laboratories Class A BIO Stock Holding History

GAM Holding’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3,000
Closed -$724K – 289
2025
Q2 		$724K Buy
+3,000
New +$709K 0.05% 207
2024
Q1 		– Sell
-1,001
Closed -$323K – 170
2023
Q4 		$323K Buy
+1,001
New +$314K 0.02% 154

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

GAM Holding's BIO Position: Q3 2025 in Review

GAM Holding sold out of Bio-Rad Laboratories Class A (BIO) in Q3 2025, closing a stake of 3,000 shares — an estimated $724K sold.

GAM Holding first reported a position in BIO in Q4 2023 and held it in 2 quarters. The position peaked at $724K in Q2 2025. 397 funds tracked by Wall St. Rank hold BIO as of Q3 2025.

  • GAM Holding reported no remaining Bio-Rad Laboratories Class A position as of Q3 2025 after selling out during the quarter.
  • GAM Holding sold 3,000 Bio-Rad Laboratories Class A shares in Q3 2025, an estimated $724K.
  • GAM Holding first reported a position in Bio-Rad Laboratories Class A in Q4 2023 and held it in 2 quarters.
  • GAM Holding's Bio-Rad Laboratories Class A position peaked at $724K in Q2 2025.
  • 397 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2025.

Based on GAM Holding's 13F filing for Q3 2025, filed 21 Oct 2025.